Original language | English |
---|---|
Pages (from-to) | 1657-1660 |
Number of pages | 4 |
Journal | Journal of the American Academy of Dermatology |
Volume | 85 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2021 |
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of the American Academy of Dermatology, Vol. 85, No. 6, 12.2021, p. 1657-1660.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI
T2 - A randomized split-body pilot study
AU - Kim, Hee J.
AU - Singer, Giselle K.
AU - Del Duca, Ester
AU - Abittan, Brian J.
AU - Chima, Margot A.
AU - Kimmel, Grace
AU - Bares, Jennifer
AU - Gagliotti, Matthew
AU - Genece, Jordan
AU - Chu, Justin
AU - Wilding, Gregory
AU - Pavel, Ana B.
AU - Guttman-Yassky, Emma
AU - Lebwohl, Mark G.
N1 - Funding Information: Funding sources: Supported by Celgene Corporation.Dr Lebwohl receives research funds from Abbvie, Amgen, Arcutis, Boehringer Ingelheim, Dermavant, Eli Lilly, Evommune, Incyte, Janssen Research and Development, LLC, Leo Pharmaceutucals, Ortho Dermatologics, Pfizer, and UCB, Inc, and is also a consultant for Aditum Bio, Allergan, Almirall, Arcutis, Inc, Avotres Therapeutics, BirchBioMed Inc, BMD Akincare, Boehringer-Ingelheim, Bristol-Myers Squibb, Cara Therapeutics, Castle Biosciences, Corrona, Dermavant Sciences, Evelo, Evommune, Facilitate International Dermatologic Education, Foundation for Research and Education in Dermatology, Inozyme Pharma, Kyowa Kirin, LEO Pharma, Meiji Seika Pharma, Menlo, Mitsubishi, Neuroderm, Pfizer, Promius/Dr Reddy's Laboratories, Serono, Theravance, and Verrica. Dr Kimmel participated on an advisory board for Ortho Dermatologics. Funding Information: Funding sources: Supported by Celgene Corporation .
PY - 2021/12
Y1 - 2021/12
UR - http://www.scopus.com/inward/record.url?scp=85101348177&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2020.12.073
DO - 10.1016/j.jaad.2020.12.073
M3 - Article
C2 - 33440217
AN - SCOPUS:85101348177
SN - 0190-9622
VL - 85
SP - 1657
EP - 1660
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 6
ER -